Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Potential Boron Neutron Capture Therapy Agent Selectively Suppresses High-Grade Glioma: In Vitro and in Vivo Exploration.
Alamón C, Dávila B, García MF, Nievas S, Dagrosa MA, Thorp S, Kovacs M, Trias E, Faccio R, Gabay M, Zeineh N, Weizman A, Teixidor F, Viñas C, Gavish M, Cerecetto H, Couto M. Alamón C, et al. Among authors: davila b. Mol Pharm. 2023 May 1;20(5):2702-2713. doi: 10.1021/acs.molpharmaceut.3c00152. Epub 2023 Apr 4. Mol Pharm. 2023. PMID: 37013916
Synthesis and Antitrypanosomal and Mechanistic Studies of a Series of 2-Arylquinazolin-4-hydrazines: A Hydrazine Moiety as a Selective, Safe, and Specific Pharmacophore to Design Antitrypanosomal Agents Targeting NO Release.
Romero AH, Aguilera E, Gotopo L, Charris J, Rodríguez N, Oviedo H, Dávila B, Cabrera G, Cerecetto H. Romero AH, et al. Among authors: davila b. ACS Omega. 2022 Dec 6;7(50):47225-47238. doi: 10.1021/acsomega.2c06455. eCollection 2022 Dec 20. ACS Omega. 2022. PMID: 36570252 Free PMC article.
Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas Disease.
Aguilera E, Sánchez C, Cruces ME, Dávila B, Minini L, Mosquillo F, Pérez-Díaz L, Serna E, Torres S, Schini A, Sanabria L, Vera de Bilbao NI, Yaluff G, Zolessi FR, Ceilas LF, Cerecetto H, Alvarez G. Aguilera E, et al. Among authors: davila b. Pharmaceuticals (Basel). 2022 Dec 23;16(1):20. doi: 10.3390/ph16010020. Pharmaceuticals (Basel). 2022. PMID: 36678516 Free PMC article.
Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project.
Baldo F, Erkens RGA, Mizuta M, Rogani G, Lucioni F, Bracaglia C, Foell D, Gattorno M, Jelusic M, Anton J, Brogan P, Canna S, Chandrakasan S, Cron RQ, De Benedetti F, Grom A, Heshin-Bekenstein M, Horne A, Khubchandani R, Ozen S, Quartier P, Ravelli A, Shimizu M, Schulert G, Scott C, Sinha R, Ruperto N, Swart JF, Vastert S, Minoia F; PReS MAS/sJIA Working Party and Paediatric Rheumatology International Trial Organization. Baldo F, et al. Rheumatology (Oxford). 2025 Jan 1;64(1):32-44. doi: 10.1093/rheumatology/keae391. Rheumatology (Oxford). 2025. PMID: 39058514 Free PMC article.
26 results